SCHEMBL1708960

SCHEMBL1708960

COC(=O)[C@H](N)C(C)(C)S

nearest known ligand 0.56

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
MAPT P10636 1/20 0.56
PTGS1 P23219 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.37
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA14 Q9ULX7 3/20 0.32
CA12 O43570 2/20 0.31
DPP4 P27487 1/20 0.31
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2420558 1.00 ALDH1A1 (0.56) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
SCHEMBL5250175 1.00 ALDH1A1 (0.56) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
Hydrochloric Acid SCHEMBL2424957 0.98 ALDH1A1 (0.54) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
Hydrochloric Acid SCHEMBL2424956 0.98 ALDH1A1 (0.54) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
Hydrochloric Acid SCHEMBL2029100 0.98 ALDH1A1 (0.54) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
SCHEMBL11720401 0.88 ALDH1A1 (0.45) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
SCHEMBL500459 0.80 SMN1; SMN2 (0.42) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
SCHEMBL20879474 0.80 SMN1; SMN2 (0.42) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
SCHEMBL500460 0.80 SMN1; SMN2 (0.42) ALDH1A1MAPTPTGS1SMN1; SMN2CA1
SCHEMBL24932901 0.79 ALDH1A1 (0.54) ALDH1A1MAPTPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210380952-A1 Method to Produce Virus in Cultured Cells Supplemented With Alpha-Ketoglutarate UNIV PRINCETON (US) 2021-12-09 US claimed
EP-3656855-A1 METHOD TO PRODUCE VIRUS IN CULTURED CELLS The Trustees of Princeton University (US) 2020-05-27 EP claimed
EP-2699672-B1 METHOD TO PRODUCE VIRUS IN CULTURED CELLS UNIV PRINCETON (US) 2019-12-25 EP claimed
US-20190218524-A1 Method to Produce Virus in Cultured Cells Supplemented With Alpha-Ketoglutarate THE TRUSTEES OF PRINCETON UNIVERSITY 2019-07-18 US claimed
US-20180298348-A1 Method to Produce Virus in Cultured Cells Supplemented With Alpha-Ketoglutarate UNIV PRINCETON (US) 2018-10-18 US claimed
US-9212349-B2 Method to produce virus in cultured cells THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2015-12-15 US claimed
US-20140113353-A1 Method to Produce Virus in Cultured Cells THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2014-04-24 US claimed
EP-2699672-A1 METHOD TO PRODUCE VIRUS IN CULTURED CELLS The Trustees of Princeton University (US) 2014-02-26 EP claimed
WO-2013158706-A1 METHOD TO PRODUCE VIRUS IN CULTURED CELLS SUPPLEMENTED WITH ALPHA-KETOGLUTARATE THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-10-24 WO claimed
WO-2012145375-A1 METHOD TO PRODUCE VIRUS IN CULTURED CELLS THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2012-10-26 WO claimed
EP-1720538-B1 METHOD FOR INDUCING CELL DEATH WITH CARBONYL SCAVENGERS UNIV ARIZONA (US) 2008-11-12 EP claimed
US-20210380952-A1 Method to Produce Virus in Cultured Cells Supplemented With Alpha-Ketoglutarate UNIV PRINCETON (US) 2021-12-09 US disclosed
WO-2020208093-A1 CYSTEINE DERIVATIVES FOR TREATMENT AND PREVENTION OF BACTERIAL INFECTIONS UNIVERSITY OF COPENHAGEN (DK) 2020-10-15 WO disclosed
EP-3656855-A1 METHOD TO PRODUCE VIRUS IN CULTURED CELLS The Trustees of Princeton University (US) 2020-05-27 EP disclosed
EP-2699672-B1 METHOD TO PRODUCE VIRUS IN CULTURED CELLS UNIV PRINCETON (US) 2019-12-25 EP disclosed
WO-2005084659-A1 METHOD FOR INDUCING CELL DEATH WITH CARBONYL SCAVENGERS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2005-09-15 WO disclosed
US-20050197400-A1 Method for inducing cell death with carbonyl scavengers NIADYNE, INC. 2005-09-08 US disclosed
US-6294573-B1 FOR THERAPY RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL, EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR GROWTH AND METASTASIS OR INVASION ABBOTT LABORATORIES 2001-09-25 US disclosed
US-5393875-A Hypotensive, cardiotonic and antiischemic agents HOFFMANN-LA ROCHE INC. (US) 1995-02-28 US disclosed
EP-0509354-A2 Amino acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1992-10-21 EP disclosed